BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
45 hedge funds and large institutions have $44.7M invested in BioSpecifics Technologies Corp. in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
45% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 11
18% more funds holding
Funds holding: 38 → 45 (+7)
10% more capital invested
Capital invested by funds: $40.8M → $44.7M (+$3.92M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$1.63M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.55M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.04M |
| 4 |
GA
Geneva Advisors
Chicago,
Illinois
|
+$501K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$441K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$4.97M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$4.76M |
| 3 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$1.1M |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$623K |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$346K |
BSTC Hedge Fund Activity: Q1 2014 in Review
45 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2014, worth a combined $44.7M — up 9.6% from $40.8M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new BSTC positions and 3 closed out — a net gain of 7 holders — while 16 added to existing stakes and 11 trimmed.
The largest buyer was Wells Fargo, adding an estimated $1.63M. The largest seller was BlackRock Advisors, cutting an estimated $4.97M.
- 45 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2014, up from 38 in Q4 2013.
- Funds reported $44.7M of BioSpecifics Technologies Corp. stock for Q1 2014, up 9.6% quarter-over-quarter.
- 10 funds opened new BioSpecifics Technologies Corp. positions in Q1 2014 and 3 closed out, a net change of +7 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q1 2014 was Wells Fargo, an estimated $1.63M added.
- The largest BioSpecifics Technologies Corp. seller in Q1 2014 was BlackRock Advisors, an estimated $4.97M sold.
Based on aggregated 13F filings for Q1 2014.